Cancer Weekly articles from October 2001

Cancer Weekly archives from October 2001

Low-Dose Topotecan Augments Antibodies Against VEGF In Wilms Tumor.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Researchers say topotecan, a cancer drug, enhances the effectiveness of antibody to vascular endothelial growth factor (VEGF) in murine models of Wilms...

HBV Immunization Before Or At Cancer Diagnosis Protects Children Best.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The optimal way to protect pediatric cancer patients against hepatitis B virus (HBV) infections is to ensure vaccination at an early age, or failing that,...

Docetaxel/Gemcitabine Is Active Against Metastatic Disease.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Combination chemotherapy with monthly docetaxel (Taxotere) and weekly gemcitabine (Gemzar) is a highly active regimen in patients with metastatic breast cancer who have received prior chemotherapy....

Shield Protects Women From Risks Associated With Treatment Scatter Damage.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Specialists at The Cleveland Clinic who provide radiotherapy for women with breast cancer are pioneering use of a shield designed to protect healthy breast tissue from scatter damage that might be...

Combination Chemotherapy, Radiation Therapy Could Increase Survival.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- A systematic review of randomized trials in the past two decades published in the September 8, 2001 issue of The Lancet concludes that women given concurrent chemotherapy and radiotherapy for...

Latent Epstein-Barr Expression May Underlie Development.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Epstein-Barr virus (EBV) infection and EBV-related gene expression may be important agents in the etiology of HIV related lymphomas, researchers in Germany...

G-CSF Glycosylation Has Little Effect On Immune Recovery.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Both glycosylated and nonglycosylated forms of granulocyte colony-stimulating factor provide similar immune recovery following chemotherapy, stem cell...

Computerized Tool Helps Predict Outcome Of Treatment.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Researchers at Memorial Sloan-Kettering Cancer Center have pioneered the use of computerized devices to help patients and their physicians decide among the major treatment choices for early stage...

Low-Intensity Conditioning Regimens Hasten Immune Recovery.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Reduced-intensity conditioning regimens lead to faster immune reconstitution after stem cell transplantation, according to researchers in Israel. Dr....

Vincristine Safe For Shrinking Tumors That Threaten Life In Infants.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The cancer therapy vincristine can be safely used to treat vascular tumors in young infants. Although vascular tumors are a relatively frequent...

Allos Names Regulatory Affairs And Clinical Development Executives.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics Inc. (ALTH) has named Markus F. Herzig Vice President of Regulatory Affairs. He will oversee Allos' national and international regulatory activities and will report to Michael J....

Cell Genesys Promotes Joseph Vallner To President.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Cell Genesys Inc. (CEGE) has promoted Joseph J. Vallner, PhD, to President from the position of Executive Vice President. Dr. Vallner will continue to serve as chief operating officer and work...

ChromaVision Names New Oncology Associate.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- ChromaVision Medical Systems Inc. (CVSN), a provider of automated cell-imaging systems and manufacturer of the ACIS system, has appointed Marc E. Lippman, MD, renowned cancer researcher, as advisor...

Natural Pharmaceuticals To Supply Boston Scientific With Paclitaxel.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corp. has entered into an agreement with Natural Pharmaceuticals Inc., under which Natural Pharmaceuticals will exclusively supply Boston Scientific paclitaxel for use with a wide...

Immunoconjugate Enhances Chemotherapy Effectiveness.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- CryoLife, Inc. announced that its wholly owned subsidiary, AuraZyme Pharmaceuticals, Inc., presented results of animal studies on its A-Z-CINN Linker for targeted delivery of anticancer chemotherapy...

Preclinical Studies Of CRL-5861 Are Encouraging.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- CytRx Corporation announced results from experimental studies investigating the combination effect of its development-stage drug, CRL-5861 (purified poloxamer 188) with the anticancer agent...

Slow Drug Approval Process In Europe Puts Patients At Risk.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Barely a month after the European Union (EU) Commission unveiled plans to speed up the process for approving new medical treatments in Europe, a new report published August 30, 2001, says the...

Enchira Attributes Second Quarter Losses To Arbitration Costs.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Enchira Biotechnology Corp., which develops anticancer therapies, announced that revenues for its second quarter were $273,965, compared with $70,468 for the same period in 2000. Enchira...

ImmunoGen Posts Losses In Fiscal Year 2001.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- ImmunoGen Inc. (IMGN) announced financial results for the 3 and 12 months ended June 30, 2001. The following financial results exclude the impact of the company's adoption of the U.S. Securities and...

NeoTherapeutics Reports Second Quarter Results.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics Inc. (NEOT, NEOTW), which develops drugs for neurodegenerative disorders, reported a net loss of $6.6 million, or $0.36 per share for the second quarter ended June 30, 2001, compared...

Second Quarter Losses Due To Stepped-up Spending on Ovarian Cancer Drug.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO), a developer of antigen-targeted antibody-based cancer therapeutics, reported a net loss of $7.5 million or $0.28 per share for the three months ended June 30, 2001 compared with...

New Drug Offers Hope To Bone Marrow Transplant Recipients.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Bone marrow transplantation (BMT) is used to improve the survival of leukemia patients who have a poor outlook following chemotherapy. However, the success of bone marrow transplantation is...

Cancer Center Fuses PET With Radiotherapy CT Planning Images.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- The Cancer Therapy & Research Center (CTRC), through its medical physics team, is now able to overlay high-resolution positron emission tomography (PET) onto Marconi CT planning images for NOMOS...

Endometrial Cancer-Related Deaths Increasing.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Gynecologic oncologists are urging women to learn more about their gynecologic health during Gynecologic Cancer Awareness Month. The rate of death from endometrial cancer has shot up by 128%...

BioReliance Will Produce Two Anticancer Drugs For MediGene.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- BioReliance Corp. (BREL) has agreed to produce clinical supplies of herpes simplex virus-derived G207 and NV1020 for the biopharmaceutical company MediGene. These products are two of MediGene's...

Novartis Seeks To Extend ZOMETA Approval To U.S.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Novartis has submitted an application to the Food and Drug Administration (FDA), seeking marketing authorization for ZOMETA (zoledronic acid for injection) in the treatment of bone complications...

Repifermin Studied In Multiple Myeloma Patients.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., announced September 4, 2001, that the company has initiated a Phase II clinical trial to examine the safety and preliminary efficacy of repifermin for the treatment of...

Institute Will Offer Focused Treatment For Rare Cancer Form.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- The University of Arkansas for Medical Sciences (UAMS) has announced plans to build the world's first institute entirely dedicated to the research and treatment of multiple myeloma, a rare form of...

Pivotal Trial Completed, Primary Analysis Underway.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO) announced that it has reached a major milestone in its OvaRex clinical development program - the completion for primary analysis of its designated pivotal 345-patient OvaRex...

Researcher Unlocks Links Between Complex Carbohydrates And Metastasis.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Research at the University of Georgia may lead to a revolutionary breed of treatments aimed at preventing the spread of cancer. Michael Pierce, a professor of biochemistry and molecular biology,...

Antisense Therapy Looks Promising In Animal Model.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Hybridon, Inc. (HYBN.OB) announced in September (2001) that investigators at the U.S. National Cancer Institute (NCI) and the U.S. National Institute on Aging (NIA) have demonstrated that GEM231, an...

Co-X-Gene Technology Will Target Advanced, Hormone-Refractory Disease.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Virax Holdings Ltd. (VHL) has entered into a collaborative agreement with Dr. Michael Brown of Royal Adelaide Hospital's Cancer Centre to develop leads for an immune-based therapy to treat prostate...

Clinical Trial Listing Service Adds 40 More Health Care Organizations.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Forty organizations, consisting mainly of nonprofit patient advocacy groups and some targeted health portals, have joined the HopeLink Syndicated Network of partners. The Hopelink network now...

FDA Places Clinical Hold On Vaccine Trials.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- AVAX Technologies Inc. (AVXT), has submitted its response to the Food and Drug Administration's (FDA) clinical holds of the company's M-Vax and O-Vax autologous cancer vaccine clinical trials....

Phase I Clinical Trial For Breast/Ovarian Cancer Initiated.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Ribozyme Pharmaceuticals, Inc., (RPI) (RZYM) announced the start of a new Phase I clinical trial relating to the safety and pharmacokinetics of its innovative compound Herzyme. Herzyme is an...

NCCRA Augments Colonoscopy Findings With Patient Education.(National Colorectal Cancer Research Alliance)(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- A study published in the New England Journal of Medicine supports the National Colorectal Cancer Research Alliance's call for colonoscopy to be recognized as the best screening method for colon...

Pharmacopeia And Eos Biotechnology To Merge.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Privately held Eos Biotechnology Inc. will merge with Pharmacopeia Inc. (PCOP) in a tax-free, stock-for-stock transaction valued at approximately $197 million, including the value of shares to be...

Promising Anticancer Agent Enters Phase I Trials.(Brief Article)
October 2, 2001... 2001 OCT 2 - (NewsRx.com & NewsRx.net) -- Antisoma plc, a United Kingdom-based biopharmaceutical company, announced that it has in-licensed DMXAA, a vascular targeting agent, from Cancer Research Ventures Limited (CRV), a global cancer...

Lung-Resistance Related Protein Linked To Poor Prognosis.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Japan have identified a protein that may be partly responsible for the high level of treatment failure in patients suffering from adult...

Immunological Gene Therapy And Tumor Debulking Delays Mesothelioma Growth.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Patients with malignant mesothelioma might benefit from augmentative therapies combining immunological gene therapy with tumor debulking. The process...

Scientist Identify High Resolution Of BRAC1 Protein.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Scientists at the University of Washington have gained a clearer picture of what the tumor suppressing protein BRAC1 looks like, information that should help them devise new ways to use this enzyme...

Gene That Prevents Tumor Growth Also Carries Messages From Circadian Clock.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Scientists have long known that the gene Nf1 is so important to development that when it is missing the condition known as neurofibromatosis results, causing tumors and sometimes leading to cancer...

Hepatitis C A Major Cause Of Cancers In Italian Population.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Although hepatitis C virus is a well-known cause of liver cancer, researchers in Italy have also linked it to several other types of cancer, particularly of...

Lymphocyte Infusions After Bone Marrow Grafts Effective But Dangerous.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Administration of donated lymphocytes after bone marrow transplantation can effectively treat refractory disease in multiple myeloma patients although this...

Study Shows Diet And Exercise Slow Cancer Cell Growth.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- A low-fat, high-fiber diet and regular exercise can slow prostate cancer cell growth by up to 30%, according to a new study by researchers at UCLA's Jonsson Cancer Center and UCLA's Department of...

Antisense Strategy Dampens Angiogenesis, Promotes Apoptosis In Neoplasms.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The authors of an Italian study suggest use of antisense technology to destroy mitogenic signaling and to prohibit the expression of antiapoptotic genes...

NeoTherapeutics Appoints Assistant Medical Director.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- NeoTherapeutics Inc. (NEOT, NEOTW) has hired Dr. Rosemarie Rosales as Assistant Director, Medical Research of its oncology subsidiary NeoOncoRx. Dr. Rosales will assist in clinical study design,...

Capecitabine In Combination With Docetaxel Offers Superior Survival.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has approved the oral cancer drug, Xeloda (capecitabine), in combination with Taxotere (docetaxel), given by infusion, for the treatment of metastatic...

Goserelin Improves Treatment Choices For Younger Women.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Pre- and perimenopausal women with hormone-sensitive early breast cancer can now be offered an equally effective alternative to standard chemotherapy following the regulatory approval of Zoladex...

Scientist Use Statistical Gene Profiling To Predict Clinical Status.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Researchers at Duke University, Durham, North Carolina, have developed a new statistical approach to classifying breast cancers based on profiles of their gene expression. Their analysis of the...

Cancer Drug Stops Messenger RNA From Reaching Tumor.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- New research uses microchips coated with DNA to discover the surprising way that the drug flavopiridol acts to kill cancer cells. This research, a collaboration among the National Institutes of...

Solving Membrane Transporter Puzzle May Aid Fight Against Drug-Resistant Bacteria.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- An x-ray crystal structure on the cover of Science provides the first detailed glimpse of a membrane transporter protein, a finding that could be useful for improving cancer therapy and fighting...

Combination Of Chemotherapy, Radiotherapy Could Increase Survival.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- A systematic review of randomized trials in the past two decades published in Lancet concludes that women given concurrent chemotherapy and radiotherapy for cervical cancer could have an increased...

Tamoxifen Attacks Cellular Processes In Gynecological Tumors.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Short-term, high-dose tamoxifen therapy attacks cervical cancers on several fronts, researchers in Rome, Italy, report. The authors of a new study list...

Bristol-Myers Squibb, ImClone To Co-Develop Cancer Therapies.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Drug maker Bristol-Myers Squibb Co. has agreed to co-develop and promote an experimental cancer drug being tested by ImClone Systems and to buy a sizable stake in the New York biotechnology company....

Full Structure Of Key Protein May Lead To Next Generation Cancer Drugs.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- After five years of transatlantic collaboration, researchers of Merck KGaA and the Massachusetts General Hospital (MGH) have solved, for the first time ever, the full structure of an integrin...

Novuspharma S.p.A Announces Interim Market Performance.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Novuspharma S.p.A (NOV.MI), a biotechnology company focused on cancer, has announced financial results for the six months ended June 30, 2001 and an update on clinical development in the second...

Wells Fargo Van Kasper Initiating Coverage On Celgene Corp., Citing Thalidomide Success.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Alan H. Auerbach, biotechnology analyst at Wells Fargo Van Kasper, has initiated coverage on Celgene Corp. (CELG) ($28.09) with a buy rating and price target of $38. Below are direct quotations...

Positive Phase II Data For IL-2 Gene Therapy Product.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Valentis, Inc. has reported that a review of the results of all 80 patients in the Phase IIb clinical trial of its IL-2 Genemedicine product were consistent with the positive results seen in the...

Bystander Effect Seen After Vector Administration.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Gene therapies containing herpes simplex enzymes might be useful for immunizing patients against the formation of new tumors, according to scientists...

Genta Receives Orphan Drug Designation For Three New Cancer Indications.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Genta Inc. (GNTA) has received notice from the U.S. Food and Drug Administration that Genasense, its lead anticancer compound, has been granted designation as an "Orphan Drug" for three additional...

Oligodeoxynucleotides Can Provoke Antileukemia Immune Response.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Certain pieces of DNA can be used to induce strong antileukemia immune responses in mice, researchers in the United States report. "Immunostimulatory...

Positive Preclinical Data From Engineered Oncolytic Virus Therapy.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Cell Genesys, Inc. has reported that preclinical studies of CV890, an oncolytic virus engineered to target and destroy liver cancer cells, demonstrated significant synergistic antitumor activity in...

Perioperative Anemia May Not Require Transfusion Treatment.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Mild anemia can often go safely untreated in patients undergoing surgery for some types of lung cancer, researchers in Greece have found. "Blood...

Biomira Initiates Exploratory Phase Ib Trial With Patient-Specific Cancer Vaccines.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Biomira USA, a subsidiary of Biomira Inc., has initiated a Phase Ib clinical trial to test safety and immunogenicity of an autologous vaccine strategy for the treatment of B-cell lymphoma. This...

Stem Cell Transplantation Superior To Peripheral Blood Treatment.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Peripheral blood progenitor cells are safer and more effective than unmodified peripheral blood for treating myeloid cancers, including acute myeloid...

Mouth Sores Could Be Early Indicators Of Deadly Disease.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Every hour, one American dies of oral cancer, and every year, over 30,000 Americans are diagnosed with this type of cancer. And while those who smoke and drink excessively have a higher risk...

New Smokeless Tobacco Product To Launch In Ohio Soon.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- The Ohio Dental Association (ODA), which strongly advocates against the use of smokeless tobacco products for their harmful effects particularly the strong link to oral cancer, isn't buying into the...

AltaRex Completes Pivotal OvaRex Clinical Trial.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- AltaRex Corp. (AXO.TO, ALXFF.OTC) has completed primary analysis of the company's designated pivotal 345-patient OvaRex trial and may be ready to submit Biologics License Application (BLA) with the...

Widespread Body Pain Doubles Risk Of Death From Cancer.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Widespread body pain seems to double risk of death from cancer, a new study indicates. The research team at the University of Manchester's Chronic Disease Epidemiology Unit monitored the rates...

Higher Intake Of Dairy Products May Increase Risk.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- According to a new study in the American Journal of Clinical Nutrition, the risk of prostate cancer in men may increase with calcium intake, especially from dairy products. As part of the...

New Medicine Approved Specifically For Localized Disease.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Casodex 150 mg (bicalutamide), developed by AstraZeneca, is the first medical treatment to receive regulatory approvals specifically for the treatment of localized prostate cancer, where watchful...

Progenics, Cytogen Team To Develop Novel Vaccine.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- PSMA Development Co. LLC has entered into an exclusive licensing agreement with AlphaVax Human Vaccines Inc. to use the AlphaVax Replicon Vector (ArV) system to create a therapeutic prostate cancer...

IMPATH Acquires Oncology Clinical Trials Network.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- IMPATH Inc. (IMPH) has purchased certain assets of Innovative Clinical Solutions Ltd. (ICSL), specifically the ICSL oncology clinical studies (OCS) network of more than 20 sites across the country....

Celgene Corp. Awarded Additional Patent Protection For Lead Immunomodulatory Drug.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Celgene Corp. (CELG) announced today that its patent portfolio now includes issued U.S. Patent No. 6,281,230 that covers the use of REVIMID, Celgene's lead IMiD (immunomodulatory drug), to treat...

Molecular Structure Of New Class Of Protease Cancer Targets Revealed.(Brief Article)
October 9, 2001... 2001 OCT 9 - (NewsRx.com & NewsRx.net) -- Corvas International Inc. (CVAS) scientists and collaborators at the Max-Planck Institute of Biochemistry in Martinsried, Germany, have unveiled the three-dimensional molecular structure of the...

Intratumoral Gene Therapy Delivery Best Approach In Primary Liver Cancer.
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The best way to administer gene therapies targeting hepatocellular carcinoma, a primary form of liver cancer, may be directly to the tumor, the results of a...

Questions Surround Tumor Development After Gene Therapy In Mice.(Brief Article)
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - A group in the U.S. has questioned whether gene therapies that use recombinant adenovirus vectors might be associated with the formation of tumors. The...

Novel Method Predicts Radiotherapy Success In Laryngeal Carcinoma.(Brief Article)
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - One way to predict whether or not laryngeal carcinoma will respond to radiotherapy is to measure microvessel number to tissue area ratios. This is...

Psoriasis Patients At Increased Risk Of Skin Cancer.(Brief Article)
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- The risk of squamous cell carcinoma is increased in patients treated for psoriasis with cyclosporin in addition to photochemotherapy (PUVA), conclude authors of a new study. Immunosuppressive...

Quantitative Wilms Tumor Gene Useful For Disease Monitoring.(Brief Article)
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A real-time method for measuring oncogene levels may be useful for monitoring disease activity in leukemia patients, according to researchers in Germany. ...

Small Doses Of Suramin Increase Paclitaxel Effectiveness.(Brief Article)
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Suramin, typically used for treating humans infected with parasitic diseases, increases the effectiveness of paclitaxel, a common cancer therapy. Suramin...

Researchers Develop Noninvasive Method Of Detecting Disease.(Brief Article)
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Alabama at Birmingham have developed a highly sensitive noninvasive method of detecting and monitoring ovarian cancer, according to a new study. About 23,400 new...

Drug Arrests Tumor Growth With Minimal Side Affects.(Brief Article)
October 16, 2001... 2001 OCT 16 - (NewsRx.com & NewsRx.net) -- The results of a clinical study of the effects of Exisulind, a new drug that has been shown to slow tumor growth in men with advanced prostate cancer, is the first of its kind to show a significant...